Synthetic organic

CCF0058981 (CCF981), 3-chlorophenyl analogue, is a noncovalent SARS-CoV-2 3CLpro (SC2) inhibitor with an IC50 of 68 nM. CCF0058981 inhibits SC1 (SARS-CoV-1 3CLpro) with an IC50 of 19 nM. CCF0058981 has antiviral efficacy and has the potential for

CCF0058981 (CCF981), 3-chlorophenyl analogue, is a noncovalent SARS-CoV-2 3CLpro (SC2) inhibitor with an IC50 of 68 nM. CCF0058981 inhibits SC1 (SARS-CoV-1 3CLpro) with an IC50 of 19 nM. CCF0058981 has antiviral efficacy and has the potential for

CCF0058981 (CCF981), 3-chlorophenyl analogue, is a noncovalent SARS-CoV-2 3CLpro (SC2) inhibitor with an IC50 of 68 nM. CCF0058981 inhibits SC1 (SARS-CoV-1 3CLpro) with an IC50 of 19 nM. CCF0058981 has antiviral efficacy and has the potential for

Rho/SRF pathway inhibitor: induces intermediate mesoderm differentiation from ESCs.

Rho/SRF pathway inhibitor: induces intermediate mesoderm differentiation from ESCs.

Rho/SRF pathway inhibitor: induces intermediate mesoderm differentiation from ESCs.

Inhibits the MRTF/SRF gene transcription pathway: antifibrotic agent.

Inhibits the MRTF/SRF gene transcription pathway: antifibrotic agent.

Inhibits the MRTF/SRF gene transcription pathway: antifibrotic agent.

Inhibits the MRTF/SRF gene transcription pathway: antifibrotic agent.

Inhibits the MRTF/SRF gene transcription pathway: antifibrotic agent.

RGS4 inhibitor.